Location: Home
  • search
  • go
  • Relate News
  • 1/16/2023NHSA Holds 2023 National Healthcare Security Conference, Laying Out Po...
  • 1/16/2023CARsgen Thera and Huadong Medicine Forms Commercialization Partnership...
  • 1/13/2023HSMAP: Chinese MedPharm Industry Operations Report 2022
  • 1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
  • 1/13/2023NHC Issues 2nd Batch of the List of Drugs Subject To Focused State Rat...
  • 1/13/2023AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...
  • 1/13/2023MNCs to Play Key Role in Improving Cardiovascular Disease Management A...
  • 1/13/2023Drug R&D and Product Registration News Digest January 2023 (2)
  • 1/12/2023Information Collection on the 8th VBP Officially Initiated
  • 1/12/2023Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...
  • 1/12/2023Porton Pharma to set up biotech park in Slovenia‘s Menges
  • 1/12/2023MNC Incubators in China (PharmaDJ)
  • 1/12/2023Fosun Sees Surge in Demand from Mainland Chinese for Omicron-focused B...
  • 1/11/2023China NMPA Approved 49 New Drugs in 2022 (PharmCube)
  • 1/11/2023Takeda's EXKIVITY® (mobocertinib) Approved China for Patients with E...
  • 1/11/2023Merck to Take Legal Action against Unauthorized Distributors of Its C...
  • 1/11/2023Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...
  • 1/11/2023Hepalink Invests $60M with TPG Biotechnology fund
  • 1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...
  • 1/10/2023Pfzier to Begin Producing Paxlovid in China Thru Local Partner within ...
  • 1/10/2023Pfizer CEO Rules Out Authorizing Paxlovid Generic in China
  • 1/10/2023Viking Thera Sues Ascletis Bio of 'Ruse' to Raid Trade Secrets
  • 1/9/2023Fake Indian COVID-19 Medicines Flood China's Black Market
  • 1/9/2023Pfizer's Negotiation with China for NRDL Listing of Covid Drug Paxlovi...
  • 1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...
  • 1/9/2023CDE Issues the List of Reference Formulations for GQCE Studies (63rd B...
  • 1/9/2023Shionogi to Diversify Sourcing of APIs and Raw Materials Away from Ch...
  • 1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...
  • 1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
  • 1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)
  • Page:117/777 Total number of articles:23289: [First][<<] [115] [116] [117] [118] [119] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group